🏥 Medicament (Medicament) - HS Code 3004.49.00.50

🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional Clearance Strategy
📌 I. Product Definition & Classification: Do You Really Understand "Medicament"?

Medicament refers to pharmaceutical preparations intended for the treatment or prevention of diseases. In international trade, this category is strictly regulated due to health and safety concerns. Based on the provided data, the specific classification for HS Code 3004.49.00.50 is determined as follows:

Key Matching Logic: * Product Name: Directly points to "Medicament" (Drug/Pharmaceutical preparation). * Purpose: Fully consistent with the HS Code definition of "medicaments used for therapeutic or prophylactic purposes" (用于治疗或预防目的的药物). * Conflict Check: There are no material or form conflicts. The classification prioritizes the intended use (therapeutic/preventive) as the primary criterion.

⚠️ Critical Distinction:
- If the product is a pure chemical ingredient without formulation → It might fall under Chapter 29.
- If it is a finished dosage form (tablets, capsules, solutions, etc.) intended for treatment → It falls under Chapter 30, specifically 3004.
- 3004.49.00.50 is the specific subheading for medicaments containing biologically active substances or other ingredients not specified elsewhere in 3004.

📦 II. HS Code Classification Details (2026 Latest Tariff Authority Comparison)

According to the provided data, there are four potential HS Codes. Below is the detailed analysis of why 3004.49.00.50 is selected, alongside the other options for comparison.

🔍 Why 3004.49.00.50 is the Best Fit:
- The summary explicitly states: "Product name directly points to medicament... purpose is fully consistent with the code definition."
- It avoids the ambiguity of "unspecified composition" (3003.49) or "other" (3003.90) by directly addressing the therapeutic purpose in Chapter 30, Section 3004 (Finished Medicaments).

💰 III. 2026 Latest Tariff Rate Details (Including Surtaxes & Policy Add-ons)

✅ Applicable Country: United States (US)
✅ Origin: China (CN) (Inferred from "Section 122" and "301" context in tax details)
✅ Effective Date: 2025/2026 (Current Policy)

🎯 1. 3004.49.00.50 —— Medicament

📌 Explanation:
- Base Rate (0%): The standard Most Favored Nation (MFN) duty for many pharmaceutical preparations is 0%.
- Section 122 Tariff (+10%): This is a specific surtax applied to certain goods from China. The data explicitly lists "122条款关税10%" (Section 122 Tariff 10%).
- Section 301 Tariff (0%): The data lists "加征关税: 0.0%", indicating that this specific HS code (3004.49.00.50) is exempt from the standard 7.5% or 25% Section 301 tariffs, likely due to healthcare exemptions.

⚠️ Important Note on FDA Regulations:
While the tariff is 10%, importing medicaments requires strict compliance with the U.S. Food and Drug Administration (FDA).
- Prior Notice: Must be filed before arrival.
- Registration: Facilities must be FDA-registered.
- NDC: National Drug Code may be required for finished products.

🛠️ IV. Customs Clearance Practical Advice (Real-World Pitfall Avoidance Guide)

✅ 1. Required Documentation Checklist (None Can Be Omitted)

✅ 2. Declaration Tips (Key Mnemonics)

🔥 "Declare Use, Not Just Name! Form Matters!"

✅ 3. Special Circumstances Handling

🌍 V. Global Main Market Clearance Comparison (2026 Latest)

📌 Conclusion:
- USA has a 10% tariff (Section 122) but is exempt from Section 301.
- Regulatory Compliance (FDA) is more critical and costly than the tariff itself.
- EU and Japan have lower or zero tariffs but have stricter pre-market approval processes (EMA, PMDA).

📌 VI. Common Errors & Pitfall Guide (Lessons Learned)

❌ Error 1: Declaring "Medicament" without specifying the dosage form (tablet, capsule, liquid).
👉 Consequence: Customs may classify it under a generic "Other" heading or reject it for incomplete information.

❌ Error 2: Ignoring FDA Prior Notice.
👉 Consequence: Cargo will be held at port, incurring demurrage fees and potential return/shredding.

❌ Error 3: Misdeclaring as "Chemical" (Chapter 29) to avoid 3004 regulations.
👉 Consequence: If found to be a finished drug, penalties, fines, and blacklisting by customs.

❌ Error 4: Assuming Section 301 applies to all Chinese pharmaceuticals.
👉 Consequence: Overpaying duties. Many medicaments are exempt from 301, but Section 122 may still apply.

✅ Correct Practice:

"Finished Medicament, Tablets, [Active Ingredient Name], 500mg, For Oral Use, FDA Registered Facility, Batch No. XYZ, Expiry: 2027"

🎯 VII. Conclusion: Professional Declaration, Save Time & Money!

🎯 Remember the Mnemonic:

🔹 "HS 3004, Tax 10%, FDA First, Don't Miss!"
🔹 "Declare Therapeutic Use, Avoid Chapter 29 Confusion, Clearance Will Be Smooth!"

📌 Tips:
- If your medicament originates from Vietnam, Mexico, Thailand, or Malaysia, check if Section 122 applies or if there are FTA benefits (e.g., USMCA, ASEAN).
- Suggest Applying for an Advance Ruling or consulting a licensed customs broker familiar with FDA products to mitigate risks.

📣 Take Action Now:

📞 Contact a professional customs broker + Provide Product CoA + File FDA Prior Notice
🚀 Ensure your medicament passes customs smoothly, complies with FDA, and maximizes profit!

✨ Professional clearance starts with accurate classification!
💼 Every dollar of duty and every hour of clearance time is worth calculating!